You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 3.230.0.0/16 has been blocked (disabled) by ‪Blablubbs‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider or colocation provider. To prevent abuse, web hosts and colocation providers may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a colocation provider's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 11:04, 19 October 2026.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪Jon Kolbert‬. The reason given is Open proxy/Webhost: See the help page if you are affected .
- Start of block: 05:35, 21 February 2024
- Expiry of block: 05:35, 21 February 2029
Your current IP address is 3.230.118.156. The blocked range is 3.230.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Use dmy dates|date=August 2023))
((Short description|Calcium and magnesium-based antacid))
((More citations needed|date=November 2008))
((infobox brand
| logo           = 
| name           = Rolaids
| image          = [[File:2013 Rolaids Packaging.jpg|175px|The current trade dress and packaging for Rolaids since September 2013 under Chattem ownership.]]
| type           = [[Antacid]]
| currentowner   = [[Chattem]] (subsidiary of [[Sanofi]])
| origin         = [[United States|U.S.]]
| introduced     = 1954
| discontinued   = 
| related        = 
| markets        = [[Americas]], the [[United Arab Emirates]] and [[Fiji]]
| previousowners = [[Warner-Lambert]]<br />[[Pfizer]]<br />[[McNeil Consumer Healthcare]]
| trademarkregistrations = 
| ambassador     = 
| tagline        = "Rolaids—that's how you spell relief"
| website        = ((URL|www.rolaids.com))
))

'''Rolaids''' is an American brand of calcium and magnesium-based [[antacid]] produced by [[Chattem]].  It was invented by [[United States|American]] [[chemist]] [[Irvine W. Grote]] in the late 1920s, and originated with manufacturing in [[Chattanooga, Tennessee]], under one of Chattem's forerunner companies, which manufactured the brand for [[Warner-Lambert]]; Warner-Lambert merged with Pfizer in 2000.

In 2006, [[McNeil Laboratories|McNeil Consumer Healthcare]], a subsidiary of [[Johnson & Johnson]], acquired the brand from [[Pfizer]] Consumer Healthcare.  In 2013, McNeil sold the brand to Sanofi,<ref>((cite news|url=http://www.nj.com/business/index.ssf/2013/01/johnson_johnson_sells_its_trou.html|title=Johnson & Johnson sells its troubled Rolaids brand to Sanofi|last=Friedman|first=Alexi|date=8 January 2013|work=[[The Star-Ledger]]|access-date=9 September 2013))</ref> following a two-year period where the brand was pulled off the market due to [[product recall]]s resulting from [[quality control]] and manufacturing issues that also kept former fellow antacid brand [[Pepcid AC]]'s "chewables" product and other fellow McNeil products like some varieties of [[Tylenol (brand)|Tylenol]] off store shelves for the same period.<ref>((cite news|url=http://www.timesfreepress.com/news/2013/jan/09/rolaids-next-on-chattems-plate/|title=Rolaids next on Chattanooga-based Chattem's plate|last=Pare|first=Mike|date=9 January 2013|work=[[Chattanooga Times Free Press]]|access-date=9 September 2013))</ref> Rolaids returned to the market at the beginning of September 2013 under Chattem ownership with new packaging, [[trade dress]], and a new liquid variety.

Rolaids tablets come in many different flavors, including original peppermint, cherry, freshmint, fruit, tropical, punch, cool mint, berry, and apple.

==2010 recall==
McNeil Consumer Healthcare voluntarily recalled Rolaids products in the Americas, the United Arab Emirates (UAE), and Fiji on January 15, 2010, in consultation with the FDA. The company initiated the recall following an investigation of consumer reports of an unusual moldy, musty, or mildewlike odor that, in a small number of cases, was associated with temporary and nonserious gastrointestinal events. These events included nausea, stomach pain, vomiting, and diarrhea. At that time, the Rolaids website carried the following statement regarding product availability: "You may have noticed that ROLAIDS® products are not available at your local retailers. We are changing some of our manufacturing facilities where our products are made, a process that will take time to complete. We apologize for the inconvenience this may be causing you. Your health and comfort are important to us, and we assure you we are working hard to get ROLAIDS® product back on store shelves."<ref>((Cite web|url=http://www.rolaids.com/product-suply|title=Rolaids® products))</ref>

Another recall was issued around December 9, 2010, as a result of foreign objects that contained metal and wood particles.<ref name=recall>((cite web|title=Frequently Asked Questions|url=http://www.rolaids.com/generic.jhtml?id=/rolaids/include/faq_decrecall.inc#3_july|date=2010-12-09|access-date=2010-12-22))</ref> The foreign materials were caused by a third-party manufacturer during the production process.<ref name=recall/> Several people complained when they took the product; they also had vomiting, strange taste, and tooth and gum injury.<ref name=recall/> After this recall, beyond the small "candy aisle" rolls and chewable lines, the Rolaids line of products was drastically reduced and disappeared from most American retailers until Chattem returned the product to the market in the fall of 2013.

==Advertising==
Rolaids' best-known commercial from the 1970s featured the famous tag line:

:''"How do you spell relief?"''
:''"R-O-L-A-I-D-S"''

In connection with the famous slogan, Rolaids sponsored the [[Major League Baseball]] award for top [[relief pitcher]]s called the [[Rolaids Relief Man of the Year Award]]. The award was given yearly from 1976 through 2012.

==Rolaids softchews==
[[Pfizer]] released a new version of Rolaids on April 6, 2006,<ref>((cite web |url=http://www.pfizerch.com/inthenews.aspx |title=Pfizer Consumer Healthcare |website=www.pfizerch.com |archive-url=https://web.archive.org/web/20060716093831/http://www.pfizerch.com/inthenews.aspx |archive-date=Jul 16, 2006))</ref> branded ''Extra Strength Rolaids Plus Gas Relief Softchews''. The product was produced as an alternative for people averse to the chalky consistency of regular Rolaids. They were widely advertised in multiple media formats.

Rolaids Softchews were originally developed and test marketed in Oklahoma City under the brand name Remegel by Warner Lambert in 1984.

==Medical information==
The [[active ingredient]]s are [[calcium carbonate]] (550&nbsp;mg) and [[magnesium hydroxide]] (110&nbsp;mg). The inactive ingredients are [[dextrose]], [[flavoring]], [[magnesium stearate]], [[polyethylene glycol]], [[Modified starch|pregelatinized starch]], sucralose and [[sucrose]]. The new Chattem varieties have increased the amount of the active ingredients in the product, up to 1000&nbsp;mg of calcium carbonate and 200&nbsp;mg of magnesium hydroxide for the "ultra strength" varieties.

Minor side effects may include constipation or stomach cramps. Serious side effects include loss of appetite, vomiting, dizziness, and headache.<ref>((cite web|url=http://www.medicinenet.com/calcium_carbonate_antacid-chewable_tablets/article.htm |title=CALCIUM CARBONATE ANTACID - ORAL (Dicarbosil, Rolaids, Titralac, Tums) side effects, medical uses, and drug interactions |publisher=Medicinenet.com |access-date=2012-08-04))</ref>

==References==
((Reflist))

==External links==
*((Official website|www.rolaids.com))

[[Category:Antacids]]
[[Category:Drugs acting on the gastrointestinal system and metabolism]]
[[Category:Products introduced in 1954]]
[[Category:Chattem]]

Pages transcluded onto the current version of this page (help):

Rolaids (edit)
Template:Ambox (view source) (template editor protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:DMCA (view source) (template editor protected)
Template:Dated maintenance category (view source) (template editor protected)
Template:Dated maintenance category (articles) (view source) (template editor protected)
Template:FULLROOTPAGENAME (view source) (template editor protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Infobox (view source) (template editor protected)
Template:Infobox brand (view source) (semi-protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:Ns has subpages (view source) (protected)
Template:Official website (view source) (template editor protected)
Template:Pagetype (view source) (protected)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:SDcat (view source) (protected)
Template:Short description (view source) (protected)
Template:Short description/lowercasecheck (view source) (protected)
Template:Template other (view source) (protected)
Template:URL (view source) (template editor protected)
Template:Use dmy dates (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Disambiguation/templates (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Infobox (view source) (template editor protected)
Module:Infobox/styles.css (view source) (template editor protected)
Module:InfoboxImage (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Ns has subpages (view source) (protected)
Module:Official website (view source) (template editor protected)
Module:Pagetype (view source) (protected)
Module:Pagetype/config (view source) (protected)
Module:Pagetype/disambiguation (view source) (protected)
Module:Pagetype/setindex (view source) (protected)
Module:Pagetype/softredirect (view source) (protected)
Module:SDcat (view source) (protected)
Module:String (view source) (protected)
Module:URL (view source) (template editor protected)
Module:Unsubst (view source) (protected)
Module:Wikitext Parsing (view source) (protected)
Module:Yesno (view source) (protected)

Return to Rolaids.

Retrieved from "https://en.wikipedia.org/wiki/Rolaids"